Literature DB >> 6154527

Inhibition by 2',3'-dideoxythymidine of retroviral infection of mouse and human cells.

P Furmanski, G J Bourguignon, C S Bolles, J D Corombos, M R Das.   

Abstract

Infection of mouse and human cells with type C murine leukemia/sarcoma viruses was inhibited by the nucleoside analogue 2',3'-dideoxythymidine (ddT). Cell growth and virus synthesis by previously infected cells were not affected by the analogue. Infection of rat cells with murine retroviruses was not inhibited by ddT.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6154527     DOI： 10.1016/0304-3835(80)90146-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  8 in total

1.  Inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxynucleoside triphosphates: template dependence, and combination with phosphonoformate.

Authors:  M C Starnes; Y C Cheng
Journal:  Virus Genes       Date:  1989-05       Impact factor: 2.332

2.  Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.

Authors:  K B Frank; P A McKernan; R A Smith; D F Smee
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

3.  Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.

Authors:  H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 4.  Design of some nucleic acid antimetabolites: expectations and reality.

Authors:  J P Horwitz
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

5.  Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.

Authors:  J E Dahlberg; H Mitsuya; S B Blam; S Broder; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Inhibition of reverse transcriptases by seminalplasmin.

Authors:  E S Reddy; M R Das; E P Reddy; P M Bhargava
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

7.  The potential of nucleotide analogs as inhibitors of retroviruses and tumors.

Authors:  R K Robins
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

8.  How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy.

Authors:  Amandine Pasquier; Sandrine Alais; Loic Roux; Maria-Isabel Thoulouze; Karine Alvarez; Chloé Journo; Hélène Dutartre; Renaud Mahieux
Journal:  Front Microbiol       Date:  2018-03-13       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.